HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danielle Braggio Selected Research

SAR405838

1/2022Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.
3/2016SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danielle Braggio Research Topics

Disease

8Neoplasms (Cancer)
01/2020 - 11/2012
4Liposarcoma
01/2022 - 03/2016
2Aggressive Fibromatosis (Desmoid)
01/2020 - 01/2019
2Sarcoma (Soft Tissue Sarcoma)
03/2016 - 01/2015
1Carcinogenesis
01/2020
1Leiomyosarcoma
01/2017
1Genomic Instability
03/2016
1Cicatrix (Scar)
11/2015
1Neurofibrosarcoma (MPNST)
01/2015
1Disease Progression
11/2012

Drug/Important Bio-Agent (IBA)

3CateninsIBA
01/2020 - 11/2015
2SAR405838IBA
01/2022 - 03/2016
2Conditioned Culture MediaIBA
01/2021 - 10/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2019
1Sorafenib (BAY 43-9006)FDA Link
01/2019
1MicroRNAs (MicroRNA)IBA
01/2018
1GemcitabineFDA Link
01/2017
1mocetinostatIBA
01/2017
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2015
1nirogacestatIBA
11/2015
1Basic Helix-Loop-Helix Transcription FactorsIBA
11/2015
1PCI 34051IBA
01/2015
1Protein Isoforms (Isoforms)IBA
01/2015
1Imatinib Mesylate (Gleevec)FDA Link
11/2012
1Tyrosine Kinase InhibitorsIBA
11/2012

Therapy/Procedure

2Therapeutics
01/2015 - 11/2012